Ilyang Bio Olmesartan Medoxomil Tablet 20mg
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Ilyang Biopharm Co., Ltd.
MFDS item code 201902970 · Approved 2019.05.08 · Insurance code 696601970
This product's status changed to Expired on 2024.05.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of essential hypertension
Essential hypertension is a condition of elevated blood pressure without any specific cause, and this medication is effective in lowering blood pressure and expanding blood vessels, thereby reducing the risk of cardiovascular diseases. By controlling hypertension, it helps prevent complications such as stroke and myocardial infarction. Therefore, this medication is used to treat essential hypertension.
The recommended initial dose is 10mg once daily, administered regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 20mg once daily. If additional blood pressure-lowering effect is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with maximum effect observed at around 8 weeks. If blood pressure is not controlled with this medication alone, thiazide diuretics like hydrochlorothiazide may be added.
This medication may cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Do not take this medication if you are allergic to it or its components, are pregnant or breastfeeding, are undergoing renal dialysis, have severe liver dysfunction, or have biliary obstruction. Patients with lactose intolerance or certain genetic metabolic disorders should not take this medication. For patients with reduced blood volume or low sodium levels, hypotension may occur at the start of treatment, so monitoring their condition is essential. Caution is needed in patients with severe heart failure, as further deterioration of kidney function may occur in patients whose kidney function depends on the renin-angiotensin-aldosterone system. Patients with impaired kidney function or kidney transplant recipients should regularly check kidney function and electrolyte status through blood tests. Due to the blood pressure-lowering effect, dizziness may occur; therefore, it is advisable to avoid activities such as working at heights or operating vehicles or hazardous machinery. This medication poses a risk of hyperkalemia; patients, especially those with heart or kidney diseases, should regularly monitor their potassium levels. Chronic diarrhea and weight loss may indicate chronic malabsorption-like intestinal disorders; therefore, consult a physician if abnormal symptoms appear during prolonged use. This medication may interact with potassium-sparing diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs; inform healthcare providers about any other medications being taken. Taking this medication during pregnancy may lead to severe side effects such as hypotension, kidney problems, and skull development issues in the fetus, so consult healthcare providers if planning to conceive or suspecting pregnancy. In breastfeeding, this medication can pass into breast milk and potentially cause side effects in infants, so it is recommended to discontinue breastfeeding or stop the medication. Safety for pediatric patients has not been established, so it is advised not to use it in children. In older adults, drug metabolism may slow down, thus requiring dose adjustments and careful monitoring. In the event of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur; notify healthcare providers immediately and seek appropriate treatment. This medication has not shown any carcinogenic or genotoxic effects with long-term use, but it is crucial to consult healthcare providers if abnormal symptoms occur.
Hives, severe swelling (angioedema), anaphylaxis, angioedema, hyperkalemia, acute renal failure, chest tightness, difficulty breathing, asthma, hives, liver function abnormality (increased liver enzyme and bilirubin levels), autoimmune hepatitis, weakness, severe allergic reactions, severe swelling, severe skin reactions, serious neurological symptoms
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain a storage temperature between 1 to 25 degrees Celsius (room temperature) to ensure the medication's efficacy and prevent deterioration.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Ilyang Biopharm Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.